Objective: The aim of present study was to evaluate our clinical decision support system (CDSS) for predicting risk of diabetic retinopathy (DR). We selected randomly a real population of patients with type 2 diabetes (T2DM) who were attending our screening programme.
Methods And Analysis: The sample size was 602 patients with T2DM randomly selected from those who attended the DR screening programme.